EUVIMEDEUVIMED entdecken
Crossref

Vaccine safety in children with genetically confirmed mitochondrial disease

Annemarie de Vreugd, Franz A Zimmermann, Katja Steinbrücker, Maaike C de Vries, Lonneke de Boer, Mirian Ch Janssen, Martina Huemer, Saskia B Wortmann

Immunology Letters · 2025

DOI: 10.1016/j.imlet.2024.106946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology Letters, 2025. Verfasst von Annemarie de Vreugd und 7 weiteren Autor:innen. Beteiligte Einrichtung: Amalia Children's Hospital, Radboudumc, Department of Pediatrics, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Vaccination, Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We here explore adverse events following immunization (AEFI) in children with mitochondrial disease (MD) recruited from two expertise centers in Austria (SALK) and The Netherlands (RUMC). Parents completed a questionnaire on the type of immunizations received and AEFI in a post-vaccination exposure period of seven days. 95 individuals were invited to this study, of whom 30 (median age 13.4 years) participated. Together these individuals had received 376 immunizations with a median of 12 vaccinations each. In 316 of 376 (84 %) vaccinations no AEFI occurred, 22 patients (73 %) never experienced any AEFI. Eight patients experienced 76 AEFI after 60 vaccinations, these were mild (redness (n = 9) /pain at injection site (n = 21), fever (n = 44), gastrointestinal complaints (n = 2)). None had a metabolic deterioration or seizures, no patient was admitted to the hospital. Although our data is limited by the small sample size, this may aid in discussing responsible immunization decisions with parents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial DiseasesVaccinationVaccinesHumansChildMaleFemaleAdolescentChild, PreschoolAustriaSurveys and QuestionnairesNetherlandsInfant

Stichwörter der Autor:innen

Adverse effectAdverse events following immunization (AEFI)EpilepsyImmunizationMetabolic deteriorationSeizureSide effectVaccination

Substanzen

Vaccines

Autor:innen und Institutionen

  • Amalia Children's Hospital, Radboudumc, Department of Pediatrics, Nijmegen, The Netherlands.
  • University Children's Hospital Salzburg, Paracelsus Medical University (PMU), Salzburg, Austria.
  • Amalia Children's Hospital, Radboudumc, Department of Pediatrics, Nijmegen, The Netherlands; Radboudumc, Department of Internal Medicine, Nijmegen, The Netherlands.
  • Department of Pediatrics, Hospital Bregenz, Bregenz, Austria; Division of Metabolism, Children's Research Centre, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Amalia Children's Hospital, Radboudumc, Department of Pediatrics, Nijmegen, The Netherlands; University Children's Hospital Salzburg, Paracelsus Medical University (PMU), Salzburg, Austria. Electronic address: s.wortman…

Zitieren

APA

de Vreugd, A., Zimmermann, F. A., Steinbrücker, K., de Vries, M. C., de Boer, L., Janssen, M. C., Huemer, M., & Wortmann, S. B. (2025). Vaccine safety in children with genetically confirmed mitochondrial disease. Immunology Letters. https://doi.org/10.1016/j.imlet.2024.106946

Vancouver

de Vreugd A, Zimmermann FA, Steinbrücker K, de Vries MC, de Boer L, Janssen MC, et al. Vaccine safety in children with genetically confirmed mitochondrial disease. Immunology Letters. 2025. doi:10.1016/j.imlet.2024.106946

BibTeX
@article{deVreugd2025,
  author = {de Vreugd, Annemarie and Zimmermann, Franz A and Steinbrücker, Katja and de Vries, Maaike C and de Boer, Lonneke and Janssen, Mirian Ch and Huemer, Martina and Wortmann, Saskia B},
  title = {Vaccine safety in children with genetically confirmed mitochondrial disease},
  journal = {Immunology Letters},
  year = {2025},
  doi = {10.1016/j.imlet.2024.106946}
}
Kostenlos starten →